4.8 Article

Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis

Eduardo Vilar-Gomez et al.

Summary: Type 2 diabetes is associated with increased risk of death and liver-related outcomes in patients with NASH-related cirrhosis, while metformin use is significantly correlated with a reduction in these risks.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis

Maya Balakrishnan et al.

Summary: In a systematic review and meta-analysis, it was found that women have a lower risk of NAFLD than men. However, once NAFLD is established, women have a higher risk of advanced fibrosis than men, especially after age 50 years.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco et al.

Summary: This study assessed the prevalence of NAFLD and liver fibrosis in patients with type 2 diabetes mellitus, revealing that at least 15% of patients with T2DM and NAFLD have moderate-to-advanced fibrosis. Screening for liver disease can be enhanced using imaging and plasma diagnostic panels, as AST/ALT alone are inadequate as initial screening markers.

DIABETES CARE (2021)

Article Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

Summary: NAFLD is a common disease that affects a significant proportion of US adults. Management typically occurs in primary care or endocrine clinics, where accurate staging for fibrosis risk through screening is crucial, requiring consistent, timely, evidence-based, and easily testable management processes.

GASTROENTEROLOGY (2021)

Article Health Care Sciences & Services

Dynamic prediction of competing risk events using landmark sub-distribution hazard model with multiple longitudinal biomarkers

Cai Wu et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2020)

Letter Gastroenterology & Hepatology

Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes

Phuc Le et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Endocrinology & Metabolism

Glycemic Targets: Standards of Medical Care in Diabetes-2019

William T. Cefalu et al.

DIABETES CARE (2019)

Review Surgery

An unjustified benefit: immortal time bias in the analysis of time-dependent events

Andreas Gleiss et al.

TRANSPLANT INTERNATIONAL (2018)

Article Gastroenterology & Hepatology

High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

Llorenc Caballeria et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012

Donna L. White et al.

GASTROENTEROLOGY (2017)

Article Mathematical & Computational Biology

Dynamic Prediction of Renal Failure Using Longitudinal Biomarkers in a Cohort Study of Chronic Kidney Disease

Liang Li et al.

STATISTICS IN BIOSCIENCES (2017)

Article Gastroenterology & Hepatology

Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

I. Doycheva et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Cardiac & Cardiovascular Systems

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

Amy R. Cameron et al.

CIRCULATION RESEARCH (2016)

Review Oncology

Repurposing metformin for cancer treatment: current clinical studies

Young Kwang Chae et al.

ONCOTARGET (2016)

Review Endocrinology & Metabolism

Insulin, insulin receptors, and cancer

R. Vigneri et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)

Review Gastroenterology & Hepatology

Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis

Siddharth Singh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Cardiac & Cardiovascular Systems

Landmark Analysis at the 25-Year Landmark Point

Urania Dafni

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)

Article Gastroenterology & Hepatology

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

HB El-Serag et al.

GASTROENTEROLOGY (2004)